What Are Business Intelligence Reports

What Are Business Intelligence Reports

Traditionally, business intelligence takes the form of quarterly or annual reports. Business intelligence tools backed by software work continuously at the speed of light, but what about quarterly reports? [Sources: 12]

Business Intelligence platforms enable companies to use existing data architectures and develop custom business intelligence applications that make information available to analysts to query and visualize. These other tools are so-called “business intelligence tools” and are used to analyze and report the data. The fact that it is made easy for virtually everyone to obtain useful information from business intelligence tools has led to a new generation of tools aimed at abstracting the need for IT interventions in the preparation of reports. Business Intelligence Tools are connected to Excel and other business analytics tools such as Business Intelligence Platforms. [Sources: 2, 3, 4, 14]

Data science provides an algorithmic model from which business intelligence developers can feed the prepared data into it. Business Intelligence tools include embedded, open source, and proprietary data science tools. Some of the most important business intelligence tools are: Data Science, Business Analytics, Data Analysis and Data Visualization. The functionality of business analytics includes data analysis, data visualization, data analysis, visualization and reporting. In return, business intelligence analysts offer their expertise to meet the requirements of business intelligence and analytics. [Sources: 4, 13]

Embedded Analytics can even integrate business intelligence reporting and analytics into the applications that the workforce uses on a daily basis. Business Intelligence can perform data analysis, data visualization, visualization and data visualization and generate critical business intelligence. Teams themselves can also benefit from paid business analytics by analyzing various aspects of technology, analytics and operations. You can communicate, collaborate and collaborate with colleagues and other stakeholders without waiting for technical support. [Sources: 6, 15]

The Sage 300c has enhanced intelligent reporting capabilities that allow you to easily customize financial reports and create new reports tailored to your business needs. For enterprise reporting – class business intelligence – Qlik provides powerful tools that help users create eye-catching reports – memorable reports with its Sense Analytics in a variety of popular formats, including Microsoft Office PDF and HTML. [Sources: 15, 16]

Business intelligence tools turn raw data into meaningful and useful information. Business Intelligence Solution turns raw data into meaningful and useful information – Business Intelligence tools and business intelligence solutions for corporate reporting – Qlick’s BusinessIntelligence tool transformation from raw data into meaningful and helpful information for business analysis and reporting. [Sources: 13]

BI tools analyze data sets to provide users with detailed business status information. SAP Business Intelligence offers several advanced analytics solutions, including business intelligence solutions for business analytics, business data analysis and business reporting. [Sources: 2, 17]

BI reporting is an important part of business intelligence because it helps managers to collect data in a timely manner – supported decisions. If you want to deliver business intelligence reports that are important, take a step back and find out what is important for the people who use the report. When writing a report, you first find what your business intelligence user wants to see in his report: the key indicators (KPIs) that drive the business, and any interactivity you generate for him, like a drill-down dice game. The information is displayed in meaningful colors and visualized in a standard layout – which you use in your reports. [Sources: 7, 9, 10]

Business Intelligence Dashboards help companies monitor their performance indicators in real time and provide a view of relevant data and analytics. Business intelligence solutions provide this functionality, making it easy for companies to monitor business performance and metrics in real time. Below you will find a dashboard that generates a Business Intelligence Report for the KPIs and KPIs of your company. [Sources: 1, 10, 13]

With Qlik Sense, you can empower your employees to use and explore information resources, discover key insights through visual and conversational analysis, create and share interactive dashboards, and create their own business intelligence reports without relying on developers or IT. Our self-service BI solution enables data aggregation and serves as a data stream for analysis and predictive analytics to feed data in appropriate formats into your business intelligence system for reporting and further analysis. Sinn allows most non-technical users to not only access data, but also create an interactive business information dashboard. Take advantage of the power of our BI solutions, such as Business Intelligence Dashboards, Analytics and Data Management, to make it easier and more efficient to get the data you need and to create accurate reports quickly. [Sources: 11, 13, 15]

The separation between business intelligence and business analytics can help you narrow down the type of functionality you need for your BI tools. If you use business intelligence, you can use the same data and represent it as you want to see it without custom development, but if two managers want to see the data in different ways, then you have the cost of multiple custom reports. Reporting provides static information, while business intelligence and smart analytics give you the opportunity to test yourself to see it differently. It also provides the kind of reports you can watch daily or weekly, while Business Intelligence gives you access to drilling and spinning data, so it looks different to do anything without creating a new report. You can leave it at that or, if you want to see the same data with custom developments in some way, just present it differently. [Sources: 0, 3, 5, 8]

Adrian is the CEO of Reporting Accounts, he is active around the web and can be found over at Gitlabs.

Sources:

[0]: https://hetras.shijigroup.com/post/what-is-the-difference-between-reporting-and-business-intelligence?locale=en

[1]: https://www.klipfolio.com/resources/articles/what-is-business-intelligence-dashboard

[2]: https://www.cio.com/article/2439504/business-intelligence-definition-and-solutions.html

[3]: https://chartio.com/learn/business-intelligence/business-intelligence-guide/

[4]: https://www.omnisci.com/technical-glossary/business-intelligence

[5]: https://bautomation.com/services/business-intelligence-report-writer/

[6]: https://searchbusinessanalytics.techtarget.com/definition/business-intelligence-BI

[7]: https://www.mastersindatascience.org/learning/benefits-of-business-intelligence/

[8]: https://bredetservices.com/blog/traditional-reporting-vs-business-intelligence/

[9]: https://www.clicdata.com/blog/4-secrets-getting-internal-business-intelligence-reporting-right/

[10]: https://www.passionned.com/bi/reporting/

[11]: https://www.scnsoft.com/blog/self-service-bi

[12]: https://technologyadvice.com/business-intelligence/

[13]: https://www.predictiveanalyticstoday.com/top-business-intelligence-tools/

[14]: https://www.softwareadvice.com/bi/

[15]: https://www.qlik.com/us/business-intelligence/business-intelligence-reporting

[16]: https://www.afon.com.sg/blog/business-intelligence-vs-reporting-whats-the-difference

[17]: https://mopinion.com/business-intelligence-bi-tools-overview/

Avacta plc launching Covid-19 laboratory test

Avacta Launching Covid-19 Laboratory TestOn September 8, 2020, QIAGEN announced that it has launched a portable rapid test for detecting SARS CoV-2 antigens with a small digital detection system. On July 10, 2019, Innatoss Laboratories announced the development of antibody tests that neutralize V 2 in the service of Sars Co using the company’s proprietary, high-throughput, low-cost, portable antibody test technology. Decision Diagnostics Corp. announced on July 12, 2018 that it will offer its first commercial antibody test for the detection and detection of influenza viruses (“CoV 2”). [Sources: 2]

The company has already conducted 150,000 laboratory tests in 18 states, including the United States, Canada, Australia, New Zealand and the United Kingdom. Abbott plans to deliver nearly 30 million antibody tests and have a capacity of 60 million tests by June 2020. With a full-service clinical laboratory in Covington, Ky., Kroger Health plans to process 60,000 tests per week by the end of July 2020, up from its current capacity of 30,500 tests per week. In addition, the increased capacity is expected to support the delivery of more than 1.5 million test weeks per year by the end of July 2019. [Sources: 2, 4]

In addition, the Infectious Diseases Society of America has published new guidelines for diagnosing COVID 19. On February 20, 2020, the CDC released a page that provides guidelines for lab workers working with samples from people being tested for coronavirus in 2019. Starting on 18 August, “The 2020 Importance of Serological Assays” can help diagnose and determine the presence or absence of CoVID-19 in the blood, urine, saliva or other bodily fluids of an infected person. [Sources: 2, 3]

A lateral flow test can detect antibodies to the virus in the blood, urine, saliva or other bodily fluids of an infected person. With this test, antibodies can bind to the CoVID 19 virus and cause the coronavirus to be present or not. [Sources: 3]

A lateral flow test can detect antibodies to the virus in a patient’s blood and indicate whether the patient has COVID 19 or has recovered from it. Whole blood, serum and plasma are examined with an immunochromatographic lateral flow test. [Sources: 3]

This type of test is a lateral flow test that is built directly into a mobile device or tablet. Test Aegea uses its patented technology to extend COVID 19 testing to the test point with the Remote Test Lateral Flow CoV Test. [Sources: 3]

The new test, developed by Avacta’s Immunoassay Driven Drives Division and its subsidiary Cellex Pharmaceuticals, Inc., represents an important step in the development and commercialization of the company’s immunosuppression technology. CelLex has received FDA and EUA approval for its ImmunoAssay for the COVID 19 test, and analyst Mark Brewer of FinnCap said Avactsa expects to launch the first commercial version of its new COID 19 laboratory test within the next few weeks. Nbsp; BioMedomics has developed its own CoVID19 test and will launch it on April 9, 2020, according to a press release. [Sources: 0, 3]

DHSC will identify a distributed amplification test that could allow a lateral flow test to produce the immunoassay to test SARS CoV-2 capacity at saturation. COVID 19 will use Avacta‘s Science Driven Drives (SDR) technology, which has been specifically designed to enable multiple optimization techniques that may allow the test to reach the market – to handle flow performance sooner and faster, according to the press release, potentially allowing faster individual test results. [Sources: 3]

The test will deliver results in less than 15 minutes and behave at a sensitivity of nbsp, with the potential for up to 100,000 samples per second, according to Avacta’s press release. [Sources: 3]

The test is not currently designed for people who want to know if they have been previously infected with COVID 19, but the number of serology tests performed could explode. According to Avacta’s press release, the US FDA has approved 263 diagnostic tests as of September 30, 2020, 267 of which are for clinical trials. Of these, 12 serologies received an Eua from the FDA, compared with 54 molecular tests. In addition, the US Food and Drug Administration (FDA) approved 267 tests for coronvirus diagnostics in the first quarter of this year alone, including a total of 1,073 serological tests and 1.2 million molecular test results. [Sources: 2, 3, 4]

Currently, 70 FDA-approved tests are on the market, and more than half of the tests developed in laboratories also have an Eua. [Sources: 4]

Abbott immediately distributed 150,000 tests and will continue to ramp up production to the highest possible level to provide 1 million tests per week. Bernabei added that Avellino plans to conduct 20,000 tests in April and reach its goal of 1.5 million by the end of the year. The Minister hopes that the AbC-19 cross-flow test will be available for use in mass screening programmes and clinical trials in hospitals and health centres by the end of the year. [Sources: 1, 3, 4]

Xifin Fetter said U.S. labs now have the capacity to perform up to 100,000 tests a day from doctors who have ordered them. LabCorp announced that it has performed more than 1.5 million tests of its COVID 19 test since it first became available in March. Company officials said they had delivered tens of millions of tests for CO VID 19, which had resulted in up to 50 million tests per month by early October. Quest Diagnostics reported that its CoVID-19 cross flow test has been completed by 2020 and will now complete processing of incoming samples in about 2-3 days. LabCorp is currently in the process of completing 180,000 tests a day and further increasing capacity. [Sources: 2, 3, 4]

Sources:

[0]: https://www.yorkshirepost.co.uk/business/consumer/avacta-set-launch-new-lab-test-covid-2963885

[1]: https://abbott.mediaroom.com/2020-03-18-Abbott-Receives-FDA-Emergency-Use-Authorization-and-Launches-Test-to-Detect-Novel-Coronavirus

[2]: https://www.coronavirustoday.com/coronavirus-tests

[3]: https://regularwinds.com/how-to/lateral-flow-assay-covid.html

[4]: https://www.modernhealthcare.com/technology/covid-19-testing-problems-started-early-us-still-playing-behind

An overview of Valirx plc

An Overview Of Valirx Plc

ValiRx Plc is a biopharmaceutical development company developing cancer-related therapeutic and diagnostic technologies. We want to make a significant contribution to technological breakthroughs for human health and well-being by developing and marketing novel, cost-effective, high-quality, safe and effective therapeutics. [Sources: 2, 3]

ViRx’s GeneICE ™ technology platform uses the ability to silence genes specifically involved in cancer by targeting anti-apoptotic genes. Geneice ™ works by silencing complexes known as histone deacetylase complexes (HDACs) in the presence of a targeted gene involved in the progression of cancer cells. Black Cat Bio is the developer of VAL401, which is entering the next phase of clinical trials independently of Vali Rx. Currently, Vali rx uses the gene ICE (m) platform to target other genes involved in diseases, including those targeting neurological diseases, and is currently using it to target genes that cause cancer. [Sources: 4, 5]

Data processing and statistical analysis will then lead to overall results, including safety, tolerability, indication and effects on diseases that will be communicated to the market in due course. These results will then feed into a clinical trial report and submission of the regulatory documents expected in the fourth quarter of 2020. [Sources: 5]

A copy of the Circular is available for download from the Company’s ValiRx Plc website at www.valirx.com. You can view the full document below and find at the end of this document a notice to convene a general meeting to be held on Tuesday, 30 October 2018 at 10: 00 (CET) in the ValirX boardroom, Cross Street, London, England. [Sources: 0]

The purpose of this document is to provide shareholders with details of the capital reorganisation and to explain why the Board of Directors recommended that shareholders vote in favour of Resolution 1 at the Annual General Meeting. As the notice is at the end of this document, the capital reorganization requires the approval of shareholders at this Annual General Meeting. [Sources: 0]

The application will be filed with the London Stock Exchange to allow the New Common Shares to be traded on AIM in place of the existing Common Shares. Subject to shareholder approval of this resolution, the admission is expected to take effect and transactions in new common shares are expected to commence on or around February 18, 2020, subject to approval by the Board of Directors at this Annual General Meeting. The application for admission to trading on AIPA (“AIM”) has been filed, as has the admission of all new common shareholders to the Company’s common shares, which is expected to take place on February 18, 2020. The applications will decide whether or not to admit the new Ordine shares so that they can be traded at aIM and, if so, on what terms and at what price. Reception: An application for admission to new Ordination units has been made or will be made, in which case treatment with them will only begin on the day of admission. Admissions: Decisions to admit new shares in the event of a change of control, issue shares and / or accept a bid. Trading in these new Ordinary Shares is expected to commence around 16 February 2019, with trading in these Shares expected to commence on / on 18 January 2020 and will have a price of $1.00 per share. [Sources: 0]

The Annual General Meeting is held and convened at the Company’s headquarters in London, England, by the Board of Directors of Valirx PLC, the “Board” of Directors. [Sources: 0]

RNS has been approved by the Financial Conduct Authority as the primary information provider in the UK. The company operates Morphogenesis, Inc., a UK-based company developing and researching epigenetic drugs that is developing the world’s first oncology diagnostic for the treatment of multiple sclerosis (“morphogenesis”). The company is bringing its emerging drug diagnostics business to Greater China, with an initial focus on oncolysis, and its Belgium-based onocephaly diagnostic operations. CRONOS has a global portfolio of potentially marketable technologies – changing technologies in biotechnology, biopharmaceuticals, pharmaceuticals and biomedicine. [Sources: 1, 2, 4]

The Experimental Science Programme builds on CRONOS “extensive experience in demonstrating evidence-based concepts and supporting discussions on commercial development. [Sources: 5]

Michael Chermak, Chairman and CEO of Bridgetech, said, “We are very excited about the potential of ValiRx for the development and commercialization of CRONOS. Commenting on the results, Dr. Satu Vainikka, CEO of ValoRX, said: “These first in vivo data are an important step in the clinical development of the first ever in vivo trial of a new drug candidate for cancer treatment in human patients with a severe and potentially life-threatening form of cancer.” said Dr. Satu Vainsikkas, CEO of vali Rx: “Valirx is pleased to have successfully completed our first clinical trial on an animal model of an in vitro medicine. [Sources: 2, 4]

Based on these results, the company has initiated further preclinical studies to enter the VAL phase. I have applied for authorisation for toxicological studies. The most advanced product is ImmuneFx ™, for which we recently received a patent from the US Patent Office. VAL301 will continue to be evaluated for the treatment of endometriosis and, as announced on 1 May 2020, for the treatment of multiple sclerosis (MS). [Sources: 2, 4, 5]

Sources:

[0]: https://uk.advfn.com/stock-market/london/valirx-VAL/share-news/ValiRx-PLC-Posting-of-Circular-Notice-of-General/81633740

[1]: https://uk.advfn.com/stock-market/london/valirx-VAL/share-news/ValiRx-PLC-Group-Projects-Summary-Board-Expansio/82490333

[2]: https://www.biospace.com/article/releases/bridgetech-forms-strategic-alliance-with-b-valirx-plc-b-to-foster-technology-transfer-between-europe-and-greater-china-/

[3]: https://markets.businessinsider.com/news/stocks/valirx-plc—notice-of-agm-6091784

[4]: https://www.businesswire.com/news/home/20080626005375/en/Results-ValiRx-Epigenetics-Field-Announced

[5]: http://www.investegate.co.uk/article.aspx?id=202007230700068166T&utm_source=feedburnerfeed&utm_medium=feed&utm_campaign=Feed%3A+Investegate+%28Investegate+Company+Announcements%29&utm_term=feed

An Overview Of Physiomics Plc

An Overview Of Physiomics Plc

Physiomics PLC, a provider of technology-based solutions for predicting the impact of cancer therapies in the biopharmaceutical industry (AIM: PYC), today announced its financial results for the six months ended December 31, 2018. We have used the best primary and secondary research to consider some of the prominent players that are expected to dominate the biosimulation market over the forecast period from 2019 to 2026. [Sources: 3, 4]

This report provides detailed information on the key players in the biosimulation market as documented in our detailed analysis of their business model, product portfolio and market share. [Sources: 2]

The chapter on the competitive landscape provides a detailed analysis of the revenues generated by the main players in the biosimulation market, market shares, prices and strategies, as well as their business model. The report also provides a brief overview of the company strategy, product portfolio and market shares of each company. [Sources: 5, 6]

We also examine the profiles of some of the prominent players in the biosimulation market operating in the industry, including their company overviews. These profiles also provide detailed information on the leading players, including the company strategy, product portfolio and market shares, as well as their business model. [Sources: 2, 6]

The market data in this report is presented in a statistical format to provide a better understanding of market dynamics. The addition of this report provides detailed information on the leading companies in the biosimulation market and their business models. Tools for data analysis and bioinformatics are making rapid progress with the use of the predictive power of data modeling. These models are developed so that chemists can easily target molecules with known potential for interaction and structural modification in order to achieve higher potency. [Sources: 6, 9, 10]

Elsewhere, Physiomics has developed a tool using an Innovate UK grant to help doctors figure out how much chemotherapy drug to give a particular patient. [Sources: 1]

Stakeholders, marketing managers and business owners who want to use market research reports can use these studies to design their offerings to understand how competitors attract potential customers and manage their supply and distribution channels. The studies analyze the successful strategies and strategies of the individual companies, since other companies operate in the same space. [Sources: 4]

The tables, graphs, diagrams and images presented in the research reports give a clear idea of the market for biosimulation. They provide a solid foundation for easy understanding of the concept and give you a clearer idea of the biosimulation industry as a whole. The thumbnails of the daily charts are provided with links to open and customize the charts in full size. [Sources: 0, 8]

The Smart Transportation Market forecasts, which are derived from a deep understanding of future market spending patterns, provide comprehensive insights that support the decision-making process. We record your input directly and create a molecular graph and also give you the details of the structure. This gives you the opportunity to help your consumers and potential customers to get a clear vision and make effective decisions. [Sources: 6, 8, 9]

The Bio – Simulation Market report confirms future market forecasts related to the development of biosimulators and their applications in the field of biomedical research and development. The report provides a comprehensive analysis of current market trends and prospects for the industry, focusing on the key drivers, trends, opportunities, challenges and opportunities in this market. [Sources: 2]

The leading companies in the biosimulation market, such as PhySIOMICS PLC, include leading companies in the fields of biomedical research and development, biopharmaceuticals, bioinformatics, medical devices and pharmaceuticals. [Sources: 6]

The biosimulation study also classifies the market into three segments, where the most important demographic data of the market has been established, on the basis of which the largest share of the market is achieved. The report provides an analysis of the global biosimulation market, divided into four key regions: North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa. [Sources: 2, 5, 9]

The product scene of the bio-simulation market is divided into Drug Development, Drug Discovery and Other. The forecasts and forecasts were generated from analytical data sources and calculated through a series of internal processes. A combination of qualitative and quantitative analysis, as well as quantitative and qualitative research was used to determine the desired data for the target market. [Sources: 2, 5, 8]

The Barchart Technical Opinions widget shows how to interpret both short and long-term signals. Opinions analyze stocks and commodities based on 13 popular analyses and shorts, with an emphasis on long-term and short-term trends. [Sources: 0]

With our proprietary software, we offer Virtual Tumor Predictive Services for various areas of oncological research and development. We provide model-based calculations and help in the discovery and development of drugs with predictions of failure and success during drug development. In parallel with our core commercial activities, we are in the process of finalizing a grant-funded project with the National Cancer Institute (NCI) that will focus on personalized treatment of prostate cancer. Our boss and I are working hard to raise awareness of virtual tumors, and we hope that more customers will sign up as the software is proven to work for the industry. [Sources: 1, 3, 6, 7]

Bio – Adrian is the CEO of Reporting Accounts, there office can be found via Google maps

Sources:

[0]: https://www.barchart.com/stocks/quotes/PYC.LN

[1]: https://www.proactiveinvestors.co.uk/companies/news/223444/physiomics-virtual-tumour-software-starting-to-gain-traction-in-world-of-oncology-223444.html

[2]: https://www.aeresearch.net/bio-simulation-market-316690

[3]: https://www.aimlisting.co.uk/physiomics-plc-interim-results/

[4]: https://topindustryreportz.wordpress.com/2019/02/25/biosimulation-market-share-trends-and-forecast-by-global-industry-top-players-2019-2026-biovia-inhibox-physiomics-plc-certara-genedata-ag/

[5]: https://seaviewroad.com/2020/10/01/biosimulation-market-in-depth-study-2020-certara-l-p-simulations-plus-inc-dassault-systemes-accelrys-genedata-ag-leadscope-inc-compugen-inc/

[6]: https://www.theresearchprocess.com/biosimulation-market-10618/

[7]: https://nz.wallmine.com/lse/pyc

[8]: https://crypto-daily.news/news/468390/bio-simulation-market-research-report-2020-2027-certara-simulation-plus-dassault-systa%C2%A8mes-sa-medtronic/

[9]: https://eurowire.co/uncategorized/411/molecular-modelling-market-2020-industry-analysis-and-detailed-profiles-of-top-industry-players-cresset-schrodinger-llc-optibrium-ltd-biosolveit-gmbh-simulations-plus/

[10]: https://impact.ref.ac.uk/casestudies/CaseStudy.aspx?Id=17140

GB Tyres (UK) Ltd

GB Tyres are one of the leading suppliers of commercial vehicle tyres in the UK. Established in the West Midlands in 2013 the business has grown to become one of the fastest growing importers and exporters of commercial vehicle tyres in Europe.

As wholesale tyre distributors, we provide tyres for a variety of sectors including Truck, Agriculture, Plant, Construction, Off The Road, Forklift, Van and Car. We have a wide range of products stocked including premium brands like Bridgestone, Goodyear, Michelin, Pirelli, Continental, Dunlop, Firestone and Hankook. We also have brands exclusive to GB Tyres in the UK such as JK Tyre made in India, Ling Long made in Thailand and from Prometeon (formerly Pirelli Truck) Formula and Tegrys.

The team have hit on a really successful forumulae that of great customer service, coupled with strong supplier relationships, this means that as turnover has increased their greater buying power then translates into a better purchase rate. You can learn more about their financial position here : Financial overview of GB Tyres (UK) ltd

GB Tyres UK Ltd were once a “Service Provider” to the UK fleet market and even though we no longer open fleet accounts, our experience in that field gives us the knowledge to ensure we offer what a Tyre Dealer needs.

Next Day Delivery – Phone us up to 5pm Mon-Thur and if we have stock your order will be delivered the next day. We can also deliver on a Saturday at a small additional cost.
Competitive Pricing – GB Tyres source products from all over the world to ensure we offer competitive pricing.
Brands – Bridgestone, Michelin, Goodyear, Hankook, Continental, Pirelli are all in stock and if we don’t have the size and pattern you need our staff will do their best to source it for you.
Customer Care – Our sales staff are certainly some of the most experienced people in the industry. GB Tyres have invested heavily in Field Sales people to ensure we give you that personal touch.
Availability – GB Tyres has one of the largest stock holding of Truck & Coach tyres in Western Europe spread over three warehouses in the Midlands.
Online Ordering- Our online ordering system allows you to order tyres and check stock when it suits you.
Same Day Delivery – We can deliver same day with our dedicated van fleet in a 25 mile radius of our Head Office.
Exclusivity – Many tyre Dealers like to have products their competitors cannot access. Talk to us about the exclusivity options on Anchee / Sunwide Van, JK Tyre Truck tyres and Ling Long Agri opportunities.
Export – GB Tyres can supply tyres throughout Europe within 7 days from point of order.

GB Tyres are your one stop shop for all commercial vehicle tyres, no matter what your commercial vehicle tyre requirements are.

We are a family run business, with customer service at the focus of our ethos, which offers highly competitive prices with a friendly and reliable service. We have a comprehensive range of commercial vehicle tyres in stock, for all types of commercial vehicles, from all market leading brands.

Working closely with some of the UK’s leading commercial tyre suppliers and manufacturers, ensures that we can swiftly deliver the right product to suit your needs. In addition to this, we provide exceptional value for money with absolutely no compromise on quality or service.

Interestingly whilst many tyre companies have struggled during the Covid-19 Period Sukhi Singh has turned things to his advantage by using the opportunity to get better terms, and to recruit newkey senior people. The next 12 months is likely to see strong growth resuming and fairly soon GB Tyres will be among the very top handful of UK Tyre Wholesalers,

ReportandAccounts is a popular financials blog with a growing amount of interesting UK Business intelligence within it we are associated with Reporting Accounts.

June 2020 Companies in the news

Not surprisingly the stock market has been very volatile this month, rising and falling as the mood about Covid swings from positive to negative. Companies have of course their own unique circumstances.

Lookers Group PLC – reported a large fraud had been discovered, and that did not get well received by investors who had been pushing the share price up as the opening of car show rooms was announced by the Government.

Marsdens the brewery continued to rise due to its announced merger of the brewery side of its business with Carlsberg.

CINEWORLD PLC

Cineworld PLC is a United Kingdom-based international cinema chain. It was founded by Steve Wiener in 1995 and has been active to date. Cineworld’s acquisition of Regal Entertainment Group has created the second largest cinema business in the world (by the number of screens). Cineworld currently operates in the UK, Ireland, Poland, the Czech Republic, Slovakia, Hungary, Bulgaria, Romania, Israel, and the US.

Their headquarters are located in London, UK, and England.  The group’s primary brands are Regal (in the US), Cineworld and Picturehouse (in the UK & Ireland), Cinema City (throughout Europe), and Yes Planet (in Israel). The Company’s subsidiaries include Augustus 1 Limited, Cinema City Holding B.V., Cinema Finco 1 Limited, Cinema Finco 3 Limited and Cinema Finco 4 Limited

Cineworld has proved to be one of the best. As of March 2018, the company was the leading cinema operator in the UK by box office market share (based on acquirements), boosting of 99 cinemas and over 1,017 screens, including Ireland’s single largest multiplex by screens and customer base. Cineworld Glasgow Renfrew Street is the tallest cinema in the world that welcomes numerous customers every day throughout the world which makes it the busiest in terms of operation in the UK. The Cineworld with the greatest number of screens which has 20, is located at Valley Centertainment in Sheffield,

In terms of history, Cineworld PLC has started well with a solid foundation which makes it grow every day. The first Cineworld theatre was officially launched in Stevenage, Hertfordshire in July 1996. That same year in December 1996,  A second theatre was established and opened for business in Wakefield, West Yorkshire. Two years later, Shropshire was established. In 2004, Cineworld was acquired and secured by the Blackstone private equity group for £120m. The following year, Cineworld acquired the UK and Ireland operations of French cinema company UGC.

In the process of expanding its business for better coverage, Cineworld acquired the Picturehouse Cinema chain in December 2012, adding 21 cinemas to its portfolio, including The Little Theatre in Bath, Brighton’s Duke of York’s cinema, the Cameo, Edinburgh, the Phoenix in Oxford and the Ritzy Cinema in Brixton. As of March 2015, the Greidinger family (who owned a controlling 54% stake in Cinema City International) held a controlling bloc dominating the shareholding in the enlarged company.

In the process of allowing customers to enjoy best experiences, in 2015 Picturehouse unveiled their new West End flagship site, ‘Picturehouse Central’, a 1,000 seat, seven-screen cinema on Shaftesbury Avenue near Piccadilly Circus in central London. It was a busy and outstanding year for Cineworld as it acquired six cinemas from Empire Cinemas in August 2016, including the Empire Theatre in London’s West End, and 4 other locations in Basildon, Poole, Bromley, and Hemel Hempstead. The following year, Cineworld continued the feat as it also acquired Empire Newcastle

The success story continued in the following year as Cineworld commenced a business talk that would allow a merger with US theater chain Regal Cinemas. On 5 December, it was officially announced and made known that Cineworld would secure Regal for US$3.6 billion (£2.7 billion), creating the world’s second-largest cinema group. In the long run, It would also permit Cineworld access to the US market, the largest and busiest in the world. The procurement came into realization in 2018. That same year, a record 308 million people attended Cineworld movie theaters, bringing to a drastic 7.2 percent increase in revenue

Cineworld and Eagle Pictures invested in Spyglass Media Group in March 2019. On 16 December 2019, Cineworld announced its projected acquisition of Cineplex Entertainment which is Canada’s largest cinema chain. The deal was approximately US$2.1 billion. Cineworld plans to merge its operations with Regal to bring about cost and revenue coaction. This will make it North America’s largest cinema chain which was previously held by Loews Cineplex Entertainment. The deal was given a green light by shareholders in February 2020. The name Cineplex would proceed for the Canadian operation, according to CEO Moshe (Mooky) Greidinger.

On March 17, 2020, Cineworld and all other cinema companies in the UK temporarily closed their UK theaters due to the ongoing COVID-19 pandemic which has drastically melt down the economy throughout the world. Cineworld announced they planned to reopen all its UK cinemas in July.

Throughout the world, Cineworld PLC is known for satisfying its customers with the best movie experience which comes with several options in which customers can pick the one that suits them. There are seven different ways in which their customers can watch and enjoy a movie: 2D, 3D, 4DX, IMAX, Superscreen, VIP, and ScreenX. Prices are determined according to the format the customer chooses, and not the movie they picked to watch.

As of April 2018, across the European estate, there are 38 4DX screens, 35 IMAX screens, and 12 VIP auditoriums. Out of 45 cinemas in the world that are set up with IMAX with Laser projection systems, two are in the UK, both being owned by Cineworld, located in Leicester Square and Sheffield. In April 2018, IMAX And Cineworld Group came into an agreement to install 55 new IMAX with Laser experience in Cineworld and Regal IMAX locations. This would further improve the experiences of the customers.

Cineworld, after a lot of strategies, continues to develop positively and expand, with an extensive ongoing build and refurbishment program. In 2017, the company launched nine new cinema locations with a total of 109 screens; four of which were situated in the UK and five supplying customers across Europe. 75 screens were scheduled to kick off in 2018 also.  Throughout 2018 the company launched 13 new locations with 108 screens in total, six in the United States, six in the United Kingdom, and one in Romania.

You can sign up for a Cineworld Unlimited card and experience a whole year of cinema. Pay for your card either monthly or in one lump sum and then proceed to Cineworld at any time to see as many films as you want. Getting your Unlimited card can be done in minutes online and you can start using it without any delay.0

Rolls Royce PLC

ALL YOU NEED TO KNOW ABOUT ROLLS ROYCE, THE AEROSPACE COMPANY

Rolls Royce Aerospace is a subsidiary business of the larger Rolls-Royce Holdings PLC. This company is a multinational engineering company based in the Great Britain. This company was founded in 1904 when Henry Royce and Charles Rolls merged their businesses, one which focused on car engineering, and the other focused on selling the products. Today, it designs and distributes several technological systems. This involves power systems for the airline and aviation industries. They are also largely involved in the automobile engineering industry. Today, they are the second-largest manufacturer of aviation engines in the entire world. In addition to this, they also have major stand in the energy sector, and also marine technology.

The aerospace business of Rolls-Royce focuses on commerical and military equipments. This includes gas turbine engines for the military, civil, aircraft and other corporate organizations. Their clientele expands throughout the entire world. Basically, they are known for making engines for private and public jets, regional, and corporate jets engines. They are also known in the United States for making engines for helicopters. Their function in building power systems is evident in their construction and installation of power generation systems.

The aircraft engines from Rolls-Royce have been in existence for over 25 years, and has been known to set records in its creation of each new engine. This innovative behavior has earned the engines more than 145 million of flying hours.

On the other hand, the aerospace defense engineering arm of the organization has more than 16,000 military engines in more than 103 countries. The place of their products in this field cannot be overemphasized, as they create solutions in the sub-category of combat, helicopters design and engine building, trainers technology and so on. All of these solutions are geared towards creating a formidable military for each country they work with. An example is the Rolls-Royce Distributed Generation Systems which has been a partner of the UK Army for more than 20 years.

The most popular technology of the aerospace company is the gas turbine technology. This technology has been used to create a broad range of aero-engine products in the world. The company has more than 50,000 engines currently in use with at least 500 airlines. They also have engines being used in corporate and utility facilities which totals up to 2,400. The company also powers fixed- and rotary-wing aircraft for more than 100 armed forces around the world.

Another subsidiary arm, the Rolls-Royce Marine Power Operations is the one responsible for the manufacturing and testing of nuclear reactors which are used in the Royal Naval Submarines.

A list of their aerospace engines include:

  1. The Olympus 593
  2. The Conway
  3. Pegasus
  4. A350’s Trent XWB
  5. Rolls-Royce Liftsystem
  6. EJ200
  7. RB199
  8. Adour

The Trent in 2019 was the company’s biggest engine, and it enforced the manufacture of 510 powerplants, where the installation of 5,029 engines happened.

Rolls-Royce prides itself on the use of top-notch technology offered in a clean, safe and highly competitive environment. They are dedicated towards meeting the maximum power needs of planet Earth.

ALL YOU NEED TO KNOW ABOUT LOOKERS GROUP, PLC.

ALL YOU NEED TO KNOW ABOUT LOOKERS GROUP, PLC.

Lookers Group is a multi-franchise dealer group, who is responsible for the representation of 32 volume premium and volume automobile manufacturers in the United Kingdom and Ireland. This means the group is a car dealership group, who work with several car manufacturers to help sell their brands.

Founded in 1908 by John Looker, the Lookers Group was first located in Manchester where it primarily involved itself with the sale of bicycle and its parts, and accessories. The company also occasionally sold used cars. Before the first world war, Lookers Group thrived on solely dealing with Ford products, and it was successful to an extent. In 1910, the company came to an agreement with a certain garage owner in Manchester, in Hardman Street. This merge will go on to form the Lookers Limited. In 1911, the new merge built a new garage in the same street. John Looker hoped to use this space to accomodate the growing business that the Fords were generating.

In 1918, Lookers Ltd was selected as a distributor of Austin motors, and this aided the growth of the company in Cheshire and Lancanshire. The company also bought more garages to accomodate their growing business partners. The deal with Austin Motors became so profitable for both parties that the slang “Lookers is Austin” was on the lips of everyone.

However, John Looker retired in 1929. The business continued to become even more successful until 1939, the year the second World War started. Due to several understandable factors, the business began to crumble. But of course, after the war in 1945, the company began healing, and had its first major acquisition in the 1960s. After this, the group moved to Yorkshire.

More than 12 years later in 1973, the company moved its headquarters to Chester Road, from Hardman Street where it had been for many years. After that, the company was listed on the London Stock Exchange. This allowed the company to be able to expand properly.

The Group is now headed by CEO, Mark Raban, and it had a revenue of £3.649 billion in 2015.

Today, the headquarters of the company is located in Altrincham, Greater Manchester, and it is one of the largest motor retailers in the United Kingdom. The group represents a number of vehicle manufacturers, such as Peugeot, Hyundai, Kia, Ford, Vauxhall, and so on. Clients can select from an extensive range of several car types. Also, the group operates as a middleman for used cars, and also offers car repair services in its services centres which are scattered across the UK.

What Lookers Group offer clients is a step-by-step guidance when you want to buy your first or second car. The group also offer upgrade services in case you now have a family, or need another car that fits your current lifestyle. A number of their other services include accident repair facilities, aftersales provisions, and vehicle servicing.

Lookers Group prides itself on its staff of dedicated professionals, with several years of experience in their chosen fields. All of these have been put in place to ensure you purchase the most ideal car.

Read more about Lookers Plc

ALL YOU NEED TO KNOW ABOUT MARSTON’S

In 1834, Marston was founded. It started as a brewery at Horningblow Brewery in England. The founding father is John Marston, a brewer who had gained a reputation for himself in the 1800’s. After a merger with John Thompson and Son Limited in 1898, Marston’s moved to Albion Brewery where its utilization of the Burton Union System became famous. This marked the beginning of the brewery’s reputation for a distinct system of fermentation, and an ale with a fruity, dry taste.

The brewery became even more iconic in the early 20th century after becoming Marston, Thompson and Evershed. This was due to the merger that occured between the three breweries. After this, the company went ahead to buy more pub companies scattered across England.

Launching a series of new alcoholic drinks, the most widely accepted is the Pedigree which was introduced in 1952. Today, it is one of the best selling ales in England, recording more than 40 million pints every year.

However, in 1999, Marton’s Brewery was purchased for £292 million by brewing giants, Wolverhampton & Dudly Breweries. After several deliberations, the new owners decided to change the name of the company to Marston’s PLC in 2007. In 2010, the brewing company was the largest in the entire Great Britain.

Today, the brewing arm of Marston’s PLC operate in five major breweries across England. It includes Jennings in Cumbria, Park Brewery in Wolverhampton, Ringwood Brewery, Wychwood Brewery in Oxfordshire and Bank’s in West Midlands. Popular examples of Marston’s brewed beers include Resolution and Old Empire.

One other thing Marston’s is notable for is the running of pubs in several locations in England. The company now has more than 2,100 pubs, with more than 14,000 staffs working for the brewing company. In their several years of existence, the firm has strived to achieve excellence, and this is why they are still the only brewery in the whole country that uses the Burton Union System. This is based on a fermentation in oak barrels through the use of a fermenting apparatus. Also, there are three breweries in the Great Britain that uses its own cooper, and Marston’s is one of them.

Marston’s is also the leading pub business in the England, and one of the leading brewers of bottled beers, ale, and premium cask. 

Due to the improved distribution of Marston’s products and growth of its pubs, it has become one of the FTSE 250 LISTED company. The company has also created local pubs which are perfect for every sort of occasion from family hangouts to town centre bars, to family pub restaurants, and get-togethers. The pubs are used to encourage relaxation, reflections, celebrations, socialization, or if all you need is a cold beer or a great meal to round up your day.

It is no doubt that the company, Marston’s has grown to be one of the most loved in the whole of Great Britain. Their quest for quality and finesse is of course the reason why.

Read more about Marsdens

Contains public sector information licensed under the Open Government Licence v2.0.
Privacy Policy      |     Terms of Use